United States:
Inherent Obviousness: Artisans Need Not Recognize Latent Properties To Challenge Claims, PTAB Litigation Blog
28 December 2016
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
On November 30, 2016, the PTAB issued decisions on the
institution of inter partes reviews of U.S. Patent No.
6,667,061 (the '061 patent), which relates to formulations for
injectable suspensions having increased viscosity. The
'061 patent is owned by Alkermes Pharma Ireland, Ltd. and
Alkermes Controlled Therapeutics, Inc. ("Alkermes"), and
is listed in the Orange Book in connection with formulations of
risperidone (Janssen Pharmaceuticals, Inc.), naltrexone (Alkermes,
Inc.), and synthetic exenatide (AstraZeneca AB). Luye Pharma
Group Ltd. ("Luye") filed a pair of petitions challenging
all but three of the twenty-three claims in the '061
patent. In the case of IPR2016-01096, the PTAB instituted an IPR
as to all challenged claims on various obviousness grounds.
Read the full article at
ptablitigationblog.com.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...